<html>
<head>PUBMED IDs for OTULIN</head>
<body bgcolor='#C5F0F2'><h1>OTULIN</h1><a href='https://pubmed.ncbi.nlm.nih.gov/23806334/'>OTULIN restricts Met1-linked ubiquitination to control innate immune signaling.</a> September 11  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23969028/'>Linear ubiquitination-mediated NF-κB regulation and its related disorders.</a> March 29  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/26085216/'>Linear ubiquitination in immunity.</a> June 21  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26670046/'>LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes.</a> September 24  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27559085/'>Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease.</a> August 26  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28189684/'>Decreased linear ubiquitination of NEMO and FADD on apoptosis with caspase-mediated cleavage of HOIP.</a> February 13  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28446710/'>Linear ubiquitin chains: enzymes, mechanisms and biology.</a> April 28  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28469620/'>NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases.</a> May 5  2017<br></body></html>
